| Document |
Document Title |
|
WO/2021/023582A1 |
Process for separating anhydrous methanesulfonic acid from a reaction mixture comprising methanesulfonic acid and sulfuric acid by distillation with at least three functional steps and the use of said methanesulfonic acid.
|
|
WO/2021/023583A1 |
A process for the manufacturing of alkanesulfonic acid by reaction of an alkane with an anhydride in the presence of sulfuric acid and a starter at ambient temperature or higher and under pressure.
|
|
WO/2021/026316A1 |
Provided herein are surfactant compounds that can be used to aid in preparation of protein samples for analysis, for example by mass spectrometry.
|
|
WO/2021/019862A1 |
The present invention provides a method for producing an aqueous tin methanesulfonate solution by dissolving tin (II) oxide in an aqueous methanesulfonic acid solution, wherein if A is the number of moles of the tin (II) oxide and B is t...
|
|
WO/2021/010337A1 |
The invention is the light-emitting compound represented by formula (1), or a salt thereof.
|
|
WO/2021/010340A1 |
The present invention is a luminescent compound represented by formula (1) or a salt thereof. (In formula (1), k represents 0 or 1; at least one of X and Y represents an optionally substituted heterocyclic group containing a nitrogen ato...
|
|
WO/2021/011440A1 |
Disclosed herein is a method for the preparation of diarylmethane dyes and triarylmethane dyes, such as Isosulfan Blue, using electrochemistry. Further disclosed is Isosulfan Blue prepared from a process employing electrochemistry, compo...
|
|
WO/2021/010331A1 |
The present invention is a light-emitting compound represented by formula (1) or a salt thereof.
|
|
WO/2021/008516A1 |
A phenyl-containing compound, an intermediate thereof, a preparation method therefor and an application thereof. Provided is a compound represented by formula I or a pharmaceutically acceptable salt thereof, where R 1, R 2, R 3, R 4 and ...
|
|
WO/2021/007663A1 |
This disclosure relates to cannabinoid derivatives of formula (I), pharmaceutical compositions comprising them, and methods of using the cannabinoid derivatives in treating or preventing a diseases associated with a cannabinoid receptor ...
|
|
WO/2021/005086A1 |
The present application refers to a method for reducing the SO3 concentration in a mixture comprising SO3 and a sulfonic acid R-SO3H, wherein R represents a moiety comprising at least 1 C-atom except for CH3, the method comprising: i. pr...
|
|
WO/2021/005508A1 |
A method for producing tris(halosulphonyl)methane or salts of same is proposed. The method comprises reacting methanetrisulphonic acid or salts of same with an anhydride-forming agent in basic or neutral conditions, thus producing a mixe...
|
|
WO/2021/007245A1 |
The disclosure provides methods for the treatment of Bipolar II Disorder, comprising administering to a patient in need thereof, a therapeutically effective amount of lumateperone, in free or pharmaceutically acceptable salt form, option...
|
|
WO/2021/001457A1 |
The present invention relates to crystalline salt forms of (R)-2-amino-3-phenylpropylcarbamate and a process for their preparation. The invention also relates to a pharmaceutical composition comprising one or more of the crystalline salt...
|
|
WO/2020/259508A1 |
The present invention relates to the field of the production of fine chemicals, and disclosed is a method for synthesizing a sun-screening agent intermediate terephthalylidene dicamphor sulfonic acid, comprising the following steps: diss...
|
|
WO/2020/258542A1 |
Provided is a method for producing taurine including: providing a reaction solution comprising alkali metal taurinate and/or alkali metal isethionate, passing at least a portion of the reaction solution through a column of basic anion ex...
|
|
WO/2020/262648A1 |
The present invention provides a compound that has an excellent pest-controlling effect and that is represented by formula (I) [in the formula, L represents an oxygen atom or CH2, E represents a C2-C10 chain hydrocarbon group or the like...
|
|
WO/2020/261752A1 |
One problem addressed by the present invention is to provide a method for producing an active light sensitive or radiation sensitive resin composition which is capable of forming a pattern that is suppressed in defects. Another problem a...
|
|
WO/2020/256862A1 |
Compositions comprising one or more amphiphilic compounds formed from vinylidene olefins may comprise: a reaction product of one or more vinylidene olefins, in which the reaction product comprises a hydrophobic portion and a hydrophilic ...
|
|
WO/2020/255585A1 |
The present invention provides a method for purifying a compound that generates an acid when irradiated with active light or radiation, said method being capable of reducing the content of metal impurities, while having excellent recover...
|
|
WO/2020/256852A1 |
Compositions comprising one or more amphiphilic compounds formed from lightly branched olefins may comprise: a reaction product of one or more lightly branched olefins, in which the reaction product comprises a hydrophobic portion and a ...
|
|
WO/2020/257336A1 |
Disclosed herein are formulations and methods for reversing one or more symptoms of cannabinoid hyperemesis syndrome (CHS) or one or more symptoms thereof, comprising parenterally administering a CB1 antagonist in an amount sufficient to...
|
|
WO/2020/254507A1 |
Compounds of general Formula (I) wherein the elements A, L, R1 and R2 have a defined meaning, and their medical and non-medical use.
|
|
WO/2020/238942A1 |
Provided is a method for preparing sodium taurate as a taurine intermediate. The method comprises the following steps: providing sodium hydroxyethyl sulfonate and an ammonia source; and placing the sodium hydroxyethyl sulfonate and the a...
|
|
WO/2020/238943A1 |
The present invention provides an ammonolysis reaction system, comprising: an ammonolysis reactor, which is a vessel for an ammonolysis reaction, the ammonolysis reaction using ammonia as an aminating agent; an ammonia separation device ...
|
|
WO/2020/232545A1 |
The present disclosure relates to new cannabinoid sulfonate esters and processes for their use to prepare cannabinoids. The disclosure also relates to the use of catalysts and catalytic processes for the preparation of cannabinoids from ...
|
|
WO/2020/229757A1 |
The present invention relates to a continuous process for filtering a suspension of 2-acrylamido-2-methylpropane sulfonic acid crystals by means of a pressurized rotary filter. The invention also relates to the polymers obtained with 2-a...
|
|
WO/2020/230800A1 |
The present application discloses a method and a compound useful in the preparation of a compound represented by formula (XI). Furthermore, the present application discloses a compound that is represented by formula (XI) and that has few...
|
|
WO/2020/225386A1 |
The invention relates to a compound of general formula (E)-I or (Z)-I, where Y is a hydroxy group or an O-M+- group, wherein M+ is a cation; Z1 is selected from the group that consists of a substituted or unsubstituted C1-C12 alkyl group...
|
|
WO/2020/222393A1 |
The present inventors have researched and made efforts to overcome the problems of currently commercially available tenofovir alafenamide hemifumarate, such as low water solubility and an oral absorption rate of only 1%, and to develop a...
|
|
WO/2020/222011A1 |
The invention relates to compounds of formula (IW-1) and to their use in treating or preventing an inflammatory disease or a disease associated with an undesirable immune response: wherein RA, RB, RC and RD are as defined herein.
|
|
WO/2020/218316A1 |
Provided is a method for producing an arylsulfonic acid ester compound which comprises: a first step, in which an arylsulfonic acid of formula (1) (wherein A is an aromatic group, B is an aromatic group substituted by a halogen atom, n i...
|
|
WO/2020/218003A1 |
Provided are: an N,N'-diarylurea derivative represented by general formula (1) (in formula (1), Z is a divalent organic group; R is an alkyl group, an alkenyl group, an alkyloxyalkyl group, an aralkyl group, an aryl group, an alkylsulfan...
|
|
WO/2020/212298A1 |
The present application refers to a process for providing anhydrous alkane sulfonic acid in purified form.
|
|
WO/2020/212543A1 |
The present invention relates to novel ophthalmic devices comprising polymerized compounds comprising a photoactive unit, said polymerized compounds, and special monomer compounds being particularly suitable for compositions and ophthalm...
|
|
WO/2020/212299A1 |
The present invention relates to a process for manufacturing of anhydrous methanesulfonic acid (MSA) and to methanesulfonic acid manufactured by said process and its uses.
|
|
WO/2020/187893A1 |
The present invention refers to a method for the production of alkane sulfonic acid, in which SO3 and an alkane are contacted with each other in the presence of a solvent, said solvent does constitute a superacid and the combination of s...
|
|
WO/2020/187155A1 |
Use of an apocynin dimer analogue derivative in preparing a medicament or a health care product for preventing and treating Parkinson's disease. The structure of the apocynin dimer analogue derivative is as shown in formula I. The apocyn...
|
|
WO/2020/187902A1 |
The present invention refers to a method for the production of haloalkane sulfonic acid, in which SO3 and an haloalkane are contacted with each other in the presence of a solvent, said solvent does not constitute a superacid and the comb...
|
|
WO/2020/187901A1 |
The present invention refers to a method for the production of haloalkanesulfonic acid, in which SO3 and an haloalkaneare contacted with each other in the presence of a solvent, said solvent does constitute a superacid and the combinatio...
|
|
WO/2020/187897A1 |
The present invention refers to a method for the production of alkane sulfonic acid, in which SO and an alkane are contacted with each other in the presence of a solvent, said solvent does not constitute a superacid and the combination o...
|
|
WO/2020/185640A1 |
A method of treating a female patient suffering from non-small cell lung cancer includes the step of administering to the patient in need thereof a composition of 2,2'-dithio-bis-ethane sulfonate, or a pharmaceutically-acceptable salt th...
|
|
WO/2020/175495A1 |
Provided is a method for producing a salt by reacting M+X- with YH so as to generate XH and M+Y-, and then removing the generated XH so as to obtain M+Y-. M+X- is a salt of a cation represented by M+ and an anion represented by X-. M+Y- ...
|
|
WO/2020/172075A1 |
Disclosed herein are novel solid forms of FXR agonist of Formula (I). The disclosure also relates to pharmaceutical compositions containing one or more of the solid forms disclosed herein, as well as methods of using the solid forms in t...
|
|
WO/2020/165062A1 |
Compounds of the formula (I) in which R1, R2, X, Y and Z have the meanings indicated in Claim 1, are inhibitors of c-Kit kinase, and can be employed for the treatment of cancer.
|
|
WO/2020/159007A1 |
The present invention relates to a method for synthesizing acyloxybenzenesulfonate, which is a bleaching activator, from an aqueous solution at a low temperature. The production unit cost can be reduced due to the production being from a...
|
|
WO/2020/158537A1 |
The main purpose of the present invention is to provide a compound with excellent balance between acid generation sensitivity and the effect of enabling achieving a composition with little color change.　This purpose is met by providing...
|
|
WO/2020/148383A1 |
The present invention relates to novel bisazo compounds of formula (I) a process for preparing said compounds, the use of said compounds in a dyeing or printing process, a process for dyeing or printing a substrate in a trichromatic dyei...
|
|
WO/2020/144098A1 |
The invention relates to surfactants of the general formula (I), wherein R is hydrogen or a linear or branched alkyl-, alkenyl-, alkylaryl- or alkenylaryl group with 5 to 25 C atoms, n is a number from 1 to 21 and m is a number from 0 to...
|
|
WO/2020/145043A1 |
Provided are: a novel sulfonium salt which exhibits high photosensitivity to g rays or h rays; and a novel photoacid generator containing a sulfonium salt which exhibits high photosensitivity to g rays or h rays, high solubility in a sol...
|
